We are delighted to invite you the “6th Inflammatory Skin Disease Summit: The Translational Revolution”, a unique and dynamic symposium, being held in The New York Academy of Medicine, New York, USA, on November 12-15, 2025.

Over the last few decades, biomedical research has unravelled a plethora of pathophysiological steps putatively important for human disease development. But it was only in the last few years that a broader translation from basic research efforts to clinical medicine has indeed occurred. This was largely made possible by the close cooperation of basic researchers and clinical investigators, aiming at the development of truly effective therapeutics. Inflammatory skin diseases such as psoriasis, atopic dermatitis, alopecia areata and vitiligo serve as an example of this successful bench-to-bedside approach. Currently, more and more therapies are approved as a result of this scientific approach, and many more are on their way.

Nevertheless, a stand-alone meeting in which inflammatory skin diseases and the translational revolution that we are currently experiencing take center stage has been lacking. After five very successful meetings in Vienna and in New York City in 2014, 2016, 2018, 2021 and 2023 we have again taken upon the task of organizing such an important in-person meeting, in order to continue this path of therapeutic revolution and extend to other inflammatory skin diseases. We want to discuss new concepts and new developments in the field of inflammatory skin diseases and to devise and explore new therapeutic strategies. For the last meetings, we had been able to attract true leaders in their fields, with more than 600 participants from all over the world. We have now established this conference on every two-year basis, with the next meeting taking place in New York in 2025.

Below are a few reasons why you should participate at this upcoming Summit:

  • Learn about the latest developments for the treatment of inflammatory skin diseases.
  • The exhibit hall will serve as a forum to lean about individual therapeutic compounds, and to critically discuss their value (efficacy, safety) to key representatives of the scientific community.
  • Interact & network with peers


We look forward to your participation at the 6th Inflammatory Skin Disease Summit in New York.




Emma Guttman, M.D., Ph.D.

Waldman Professor and System Chair

The Kimberly and Eric J. Waldman Department of Dermatology

Director, Center of Excellence in Eczema

Director, Laboratory of Inflammatory Skin Diseases

Icahn School of Medicine at Mount Sinai

New York, NY, USA

James G. Krueger, MD, PhD

Director, Milstein Medical Research Program

Senior Attending Physician

D. Martin Carter Professor in Clinical Investigation

Laboratory of Investigative Dermatology

The Rockefeller University New York, NY, USA

Georg Stingl, MD

Professor emeritus

Department of Dermatology

Medical University of Vienna, Vienna, Austria

Patrick M. Brunner, MD, MSc

Associate Professor of Dermatology

The Kimberly and Eric J. Waldman Department of Dermatology

Director of the Cutaneous Lymphoma Clinic

Icahn School of Medicine at Mount Sinai,

New York, NY, USA